Two-hit therapy for breast tumors using approved drugs looks promising in animal study

Disabling a cancer-causing pathway and administering an immune-molecule-based mop-up therapy eradicated a specific type of breast tumor in mice, report investigators. This therapy, when translated for use in people humans, would be beneficial in reducing toxicity because the amount of antibody could be decreased by two-thirds and the amount of chemotherapy by at least half, they say. (Mehr in: Cancer News — ScienceDaily)